{"nct_id":"NCT02659059","title":"Nivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer","status":"COMPLETED","status_verified_date":"2023-03","start_date":"2016-02-15","start_date_type":"ACTUAL","primary_completion_date":"2018-06-22","primary_completion_date_type":"ACTUAL","completion_date":"2022-03-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}